BioCentury
ARTICLE | Company News

Peninsula, Shionogi deal

June 2, 2003 7:00 AM UTC

Peninsula gained from Shionogi exclusive development and marketing rights to doripenem ( S-4661), a broad spectrum antibiotic. The compound, which is in the carbapenem class of antibacterials, has sho...